You are here

Novartis

Novartis' Fabhalta is first FDA-approved therapy for rare disease C3G

Pharmaphorum

Fri, 03/21/25 - 11:19 am

C3 glomerulopathy

Novartis details intrathecal Zolgensma data in bid to reach more SMA patients with gene therapy

Fierce Pharma

Wed, 03/19/25 - 11:25 am

spinal muscular atrophy

Swiss drugmakers Novartis and Roche ditch some diversity programs on U.S. concerns

CNBC

Wed, 03/19/25 - 11:21 am

Novartis plans 427 layoffs in New Jersey as looming Entresto patent cliff sparks marketing refresh

Fierce Pharma

Tue, 03/18/25 - 11:13 am

Novartis CEO says it is watching US reciprocal tariff policy 'very carefully'

MSN/Reuters

Mon, 03/17/25 - 10:14 am

NFL signs Novartis as first pharmaceutical partner-source

Pharma Live

Thu, 03/13/25 - 11:26 am

pharma marketing

Roche touts head-to-head data for Xolair against oral immunotherapy for treating food allergies

Fierce Pharma

Tue, 03/4/25 - 10:48 am

Novartis, Roche grant CEO pay raises for 2024 as sales grew at the Swiss pharma giants

Fierce Pharma

Wed, 02/19/25 - 09:52 pm

Thomas Schinecker

Novartis inks $925M Anthos takeover to buy back phase 3 clot-busting candidate

Fierce Biotech

Tue, 02/11/25 - 11:42 am

Anthos Therapeutics

How pharma and health ads performed at Super Bowl LIX

Medical Marketing and Media

Tue, 02/11/25 - 11:16 am

DTC advertising

Hims & Hers Health

With uncertainty roiling Big Pharma, execs are placing lower-risk bets

Pharma Voice

Fri, 02/7/25 - 11:16 am

Pfizer taps a former Novartis exec to lead cancer drug push

BioPharma Dive

Thu, 02/6/25 - 11:38 am

Novartis gives up on anti-CD40 antibody to treat Sjögren's due to 'benefit/risk profile'

Fierce Biotech

Fri, 01/31/25 - 11:14 am

Sjögren’s syndrome

Swiss pharma giant Novartis posts better-than-expected fourth-quarter sales

CNBC

Fri, 01/31/25 - 11:13 am

Novartis to Make Super Bowl 2025 Debut with Breast Cancer Commercial

Xtalks

Thu, 01/30/25 - 11:24 pm

DTC advertising

After an obesity stumble, BioAge reconnects with its longevity pipeline

Pharma Voice

Wed, 01/22/25 - 11:20 am

Novartis's U.S. patent for Entresto upheld by appeals court

Marketscreener

Mon, 01/13/25 - 05:45 pm

Broader population could benefit from Novartis spinal muscular atrophy treatment

Clinical Trials Arena

Mon, 01/13/25 - 05:39 pm

Light Horse lassos Novartis partnership worth up to $1B, wrangles $62M series A

Fierce Biotech

Thu, 01/9/25 - 09:29 pm

Light Horse Therapeutics

genetic screening

Positive data could expand use of Novartis’ gene therapy for SMA

Clinical Trials Arena

Fri, 01/3/25 - 11:02 am

Pages